David Grayzel

Managing Director
Specializes in novel therapeutics, often focusing on companies nearing first human clinical trials. Committed to advancing pioneering healthcare solutions.

Investor scope

Investment criteria breakdown.
Investment stages
Seed
Series A
Target regions
USA
Investment ranges
$100K - $500K
$500K - $1M
Focus areas
Not found

Related unicorns

A glimpse at some of the $1B+ valuation companies backed by this fund.

Investors targeting related sectors

No partner found.

Related Sector Funds

Funds investing in similar sectors.
We couldn't find any funds that match this selection 🥺

Browse more categories